Search filters

List of works by James S Novak

Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD

scientific article published in 2023

Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle

scientific article published on 15 January 2018

Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle.

scientific article

Effect of endurance exercise on microRNAs in myositis skeletal muscle-A randomized controlled study.

scientific article published on 22 August 2017

Effect of genetic background on the dystrophic phenotype in mdx mice.

scientific article

Elusive sources of variability of dystrophin rescue by exon skipping

scientific article

Greater Colo-Rectal Activation Phenotype in Exercised mdx Mice.

scientific article published on 2 May 2018

Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy

scientific article published on 04 August 2020

Mitochondrial dysfunction and role of harakiri in the pathogenesis of myositis

scientific article published on 18 July 2019

Morpholino-induced exon skipping stimulates cell-mediated and humoral responses to dystrophin in mdx mice

scientific article published on 16 April 2019

Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle

scientific article published on 16 October 2017

Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.

scientific article published on 28 July 2017

Shorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMD

scholarly article by Ugur Akpulat et al published 10 October 2018 in Molecular therapy. Nucleic acids

TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy

scientific article published on 26 August 2015

The macrophage as a Trojan horse for antisense oligonucleotide delivery

scientific article published in June 2018